Symbol: |
VEGFB
|
Description: |
vascular endothelial growth factor B [Source:HGNC Symbol;Acc:12681]
|
Location: |
Chr11:64002010-64006259[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:160
Gene |
Compound |
Gen_sig |
Exp_pattern |
VEGFB |
6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- |
0.028 |
Up |
VEGFB |
NSC 103704 |
0.032 |
Up |
VEGFB |
NSC 113491 |
0.048 |
Up |
VEGFB |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.011 |
Up |
VEGFB |
Cyclo-C |
0.049 |
Up |
VEGFB |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.017 |
Up |
VEGFB |
TZT |
0.034 |
Up |
VEGFB |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.002 |
Up |
VEGFB |
METHYLUNDECYLPIPERIDINE, TRANS |
0.043 |
Up |
VEGFB |
Bromocriptine methanesulfonate |
0.048 |
Up |
VEGFB |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.006 |
Up |
VEGFB |
NSC 175296 |
0.035 |
Up |
VEGFB |
NSC 17753 |
0.01 |
Up |
VEGFB |
2-Imidazoline-1-ethanol, .alpha.,4,4-trimethyl-2-undecyl- |
0.006 |
Up |
VEGFB |
NSC 201902 |
0.023 |
Up |
Expression pattern: Sensitivity / Resistance
Total:11 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:17
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
|